WFDC2 and ovarian carcinoma: While CA125 is elevated in over 90% of advanced-stage ovarian cancers and 50–60% of early-stage cases, the combination of HE4 and CA125 enhances diagnostic accuracy, achieving 76.4% sensitivity and 95% specificity [67].